Web Analytics

3 Latest Announced Rounds

  • $1,000,000
    Pre-Seed

    3 Investors

    Technology, Information and Internet
    Jun 27th, 2025
  • $12,000,000
    Series A
    Mental Health Care
    Jun 27th, 2025
  • $8,000,000
    Seed

    2 Investors

    Software Development
    Jun 27th, 2025
$1,962.72M Raised in 58 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Loyal / Cellular Longevity

start up
United States - San Francisco, CA
  • 22/03/2024
  • Series B
  • $45,000,000

Loyal is part of Cellular Longevity, a company working to develop the first drugs explicitly intended to extend healthspan and lifespan — first in dogs, and then in humans, too.

By quantifying and controlling the mechanisms of aging, we hope to delay the onset and reduce the severity of age-related diseases, which means more, healthier years for both species.

At Loyal, our first products to market are focused on longevity and healthspan in dogs. Join us in our mission to help dogs everywhere.


Related People

Celine HaliouaFounder

Celine Halioua United States - San Francisco, California

Interested in: the biology of aging, the impact of healthcare inequality, economics of novel therapeutics, early-stage biotech venture capital. www.celinehh.com